Contact

Click here for a confidential contact or call:

1-347-417-2192

Healthcare Fraud

This archive displays posts tagged as relevant to healthcare fraud.

You may also be interested in the following pages:

Page 126 of 128

How to Sell a Disease – The Low-Testosterone Marketing Blitz

Posted  08/22/13
By Gordon Schnell Decreased energy.  Depressed mood.  Diminished muscle mass.  Dampened sex drive.  These are the daily woes facing millions of middle-aged American men.  It is all caused by a deficiency of the mighty male hormone testosterone, a condition better known these days as Low-T.  The problem is that the principal promoter of this diagnosis is not from within the medical establishment.  It is the...

August 21, 2013

Richard S. Obedian, orthopedic surgeon, agreed to pay the government $388,000 to settle allegations that he violated the False Claims Act by submitting false claims to Medicare for minimally invasive spine procedures. DOJ

Another Preemption Decision Sheltering Drug Makers from Liability

Posted  07/24/13
By Marlene Koury Pharmaceutical companies are on a roll.  They continue to prevail in court by relying on the preemption doctrine to block injured consumers from suing over defective drugs.  First, in the recent Mutual Pharmaceutical v. Bartlett and PLIVA v. Mensing decisions, the Supreme Court held that federal law bars suits against generic drug companies for defects in the design or labeling of their...

Beware of Internet Pharmacies

Posted  07/11/13
By Gordon Schnell If they seem like they are too good to be true, they most likely are.  That was the central message coming out of the latest FDA sweep of Internet pharmacies.  It resulted in the shuttering of 1,677 pharmacy websites for selling counterfeit, substandard or unsafe drugs.  Thousands more received regulatory warnings.  It was all part of the FDA's ongoing global crusade -- in partnership with...

Supreme Court Further Limits Liability of Generics for Faulty Drugs

Posted  07/3/13
By Gordon Schnell In what is being hailed as a major victory for generic drug makers (but not necessarily for consumers), the Supreme Court ruled last week that these companies cannot be held liable for defects in the design of their products.  The decision follows from the Court's 2011 ruling that similarly shielded the generics from liability for inadequate safety warnings on their drug labels.  Taken together,...

Breaking Further into the Black Box of Hospital Pricing

Posted  05/15/13
By Gordon Schnell It was only a few months ago that a groundbreaking study out of the University of Iowa's Carver College of Medicine empirically demonstrated what we pretty much already know about hospital pricing.  That it is subject to a complete lack of transparency and a total disconnect from the regular forces of supply and demand.  The study surveyed 120 hospitals across the country on their pricing for a...

More Doctors Speak Out on the High Cost of Cancer Drugs

Posted  05/3/13
By Gordon Schnell It is becoming a more common occurrence these days.  Doctors taking a strong and very public stand against what they perceive to be out-of-control pricing for cancer drugs.  A few months ago, it was the famed Memorial Sloan-Kettering Cancer Center refusing to use for its patients a new drug called Zaltrap for treating advanced colorectal cancer.  Now, it is a global gathering of prominent...

Caffeine Overload – Continued Concerns Over Health Risks of High Energy Drinks on Kids

Posted  04/16/13
By Gordon Schnell They are supposed to be an antidote to the fast-paced, frenzied life we lead where there is too much to do and not enough time to do it.  At least that is one of the ways so-called high energy drinks are marketed.  These are those highly concentrated caffeine concoctions sold by the likes of Monster Beverage, Red Bull and Rockstar Energy which are designed to give you that extra boost when you...

High Court to Hear Argument on Whether Injured Patients Can Hold Generic Drug Makers Accountable for Their Defective Drugs

Posted  03/13/13
By Jason Enzler Next Tuesday the Supreme Court is scheduled to hear oral argument on Mutual Pharmaceutical’s appeal of a $21 million jury award for serious injuries caused by one of its generic drugs.  Much more is at stake than the money, however, with many expecting the Justices to set out a broad rule on whether any patient can sue a generic drug maker for defects in the design of its drug. The underlying...

Buying Blind – New Study Shows Continued Lack of Transparency in Healthcare Pricing

Posted  02/28/13
By Gordon Schnell It has been talked about for years as a way to rein in the runaway costs of healthcare in this country -- making price matter to the consumer.  That is how it is with every other kind of purchase.  Whether it is a car, a house, a college education, a new pair of sneakers, or even a quart of milk, virtually everyone weighs heavily into their purchase decision what it is ultimately going to...